评估自由呼吸呼吸触发(导航)三维T1加权梯度回波序列(LAVA)在囊性和实性肾脏肿块强化检测中的应用
本研究对比自由呼吸导航触发三维T1加权MRI(NAV-LAVA)与屏气(BH)-LAVA在44例患者105个肾脏肿块(71个非强化囊肿、14个囊性及20个实性肿块)中的表现;NAV-LAVA减影质量与强化检测能力与BH-LAVA相似,但图像质量、锐利度较低且运动伪影增加;对屏气不佳者可考虑NAV-LAVA。
要点
- NAV-LAVA减影质量与BH-LAVA无差异(p=0.09-0.14),可评估强化。
- NAV-LAVA图像质量、锐利度低于BH-LAVA,运动伪影更多。
- NAV-LAVA对肾脏肿块强化检测的敏感度、特异度、AUC与BH-LAVA相似。
核心结论
- NAV-LAVA在肾脏肿块中显示与BH-LAVA相似的减影质量和强化检测能力,但图像质量、图像锐利度较低且运动伪影增加;NAV-LAVA可考虑用于屏气欠佳的肾脏MRI患者。
研究设计与样本
- 经IRB豁免的对比研究,纳入2016至2017年间44例患者共105个肾脏肿块(71个非强化囊肿、14个囊性及20个实性肿块),均行BH-LAVA和NAV-LAVA,基于增强前与增强后3分钟图像生成减影图像,由两名盲法放射科医师评估。
关键影像表现/征象
- NAV-LAVA的总体图像质量、图像锐利度较BH-LAVA差,运动伪影较BH-LAVA多(两名医师p=0.002-0.141)。
- NAV-LAVA与BH-LAVA的图像减影质量无差异(p=0.09-0.14)。
诊断标准与关键数值
- BH-LAVA减影法检测强化:医师1敏感度64.7%、特异度98.6%、AUC 0.82;医师2敏感度61.8%、特异度95.8%、AUC 0.79。
- NAV-LAVA减影法检测强化:医师1敏感度58.8%、特异度95.8%、AUC 0.79(p=0.16);医师2敏感度58.8%、特异度88.7%、AUC 0.73(p=0.37)。
- BH-LAVA的Δ%SI定量法检测强化:敏感度70.6%、特异度81.7%、AUC 0.76。
- NAV-LAVA的Δ%SI定量法检测强化:敏感度73.5%、特异度76.1%、AUC 0.75(p=0.74)。
临床应用与阅片要点
- NAV-LAVA可考虑用于屏气欠佳的肾脏MRI患者评估肿块强化。
- NAV-LAVA图像质量、锐利度较低且运动伪影较多,阅片时需注意。
- NAV-LAVA减影质量及强化检测能力与BH-LAVA相似,可作为替代序列。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: To evaluate free-breathing Navigator-triggered 3-D T1-weighted MRI (NAV-LAVA) compared to breath-hold (BH)-LAVA among cystic and solid renal masses.
MATERIALS AND METHODS: With an IRB waiver, 44 patients with 105 renal masses (71 non-enhancing cysts and 14 cystic and 20 solid renal masses) underwent MRI between 2016 and 2017 where BH-LAVA and NAV-LAVA were performed. Subtraction images were generated for BH-LAVA and NAV-LAVA using pre- and 3-min post-gadolinium-enhanced images and were evaluated by two blinded radiologists for overall image quality, image sharpness, motion artifact, and quality of subtraction (using 5-point Likert scales) and presence/absence of enhancement. Percentage signal intensity change (Δ%SI) = ([SI.post-gadolinium-SI.pre-gadolinium]/SI.pre-gadolinium)*100, was measured on BH-LAVA and NAV-LAVA. Likert scores were compared using Wilcoxon's sign-rank test and accuracy for detection of enhancement compared using receiver operator characteristic (ROC) analysis.
RESULTS: Overall image quality (p = 0.002-0.141), image sharpness (p = 0.002-0.031), and motion artifact were better (p = 0.002) comparing BH-LAVA to NAV-LAVA for both radiologists; however, quality of image subtraction did not differ between groups (p = 0.09-0.14). Sensitivity/specificity/area under ROC curve for enhancement in cystic and solid renal masses using subtraction and %SIΔ were (1) BH-LAVA: 64.7%/98.6%/0.82 (radiologist 1), 61.8%/95.8%/0.79 (radiologist 2), and 70.6%/81.7%/0.76 (%SIΔ) versus 2) NAV-LAVA: 58.8%/95.8%/0.79 (radiologist 1, p = 0.16), 58.8%/88.7%/0.73 (radiologist 2, p = 0.37), and 73.5%/76.1%/0.75 (%SIΔ, p = 0.74).
CONCLUSIONS: NAV-LAVA showed similar quality of subtraction and ability to detect enhancement compared to BH-LAVA in renal masses albeit with lower image quality, image sharpness, and increased motion artifact. NAV-LAVA may be considered in renal MRI for patients where BH is suboptimal.
KEY POINTS: • Free-breathing Navigator (NAV) 3-D subtraction MRI is comparable to breath-hold (BH) images. • Accuracy for subjective and quantitative diagnosis of enhancement in renal masses on NAV 3-D T1W is comparable to BH MRI. • NAV 3-D T1W renal MRI is useful in patients who may not be able to adequately BH.
引用
- Tu W, Alzahrani A, Currin S, et al. Evaluation of a free-breathing respiratory-triggered (Navigator) 3-D T1-weighted (T1W) gradient recalled echo sequence (LAVA) for detection of enhancement in cystic and solid renal masses. Eur Radiol. 2018. PMID: 30506224. doi:10.1007/s00330-018-5839-7
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。